FIRM FIXED PRICENO SET ASIDE USED.

XLCARE PHARMACEUTICALS INC - NEW AWARD FOR LEVETIRACETAM TABLETS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD FEB 5, 2026 TO MAY 23, 2026, WITH FOUR ONE-YEAR OPTIONS.

PIID: 36E79726D0019Solicitation ID: 36E79726R0001
Signed Date: Feb 5, 2026Effective Date: May 24, 2026
Vendor
XLCARE PHARMACEUTICALS INC
NAICS
325412
Signed Date
Feb 5, 2026

Key Details

Dollars Obligated
Base & All Options
$9.6M
Awarding Sub-Agency
Department of Veterans Affairs
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
5

Description

NEW AWARD FOR LEVETIRACETAM TABLETS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD FEB 5, 2026 TO MAY 23, 2026, WITH FOUR ONE-YEAR OPTIONS.

Context & Analysis

On Feb 5, 2026, Department of Veterans Affairs to XLCARE PHARMACEUTICALS INC for new award for levetiracetam tablets with xlcare pharmaceuticals. ordering period feb 5, 2026 to may 23, 2026, with four one-year options.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 5 offers received. The procurement used a NO SET ASIDE USED. set-aside.

Contractor Information

UEI: MEAUS5WHBJJ7
CAGE Code: 86SL9
Location: LAWRENCEVILLE, GA

Stay Updated

Get notified about new opportunities matching your interests.

Related